Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study.

Hansson J, Bartley K, Karagiannis T, Grob JJ, Kunstfeld R, Dréno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L, Meyer N, Guillot B, Dummer R, Fife K, Ernst DS, Yim YM, Dimier N, Fittipaldo A, Basset-Séguin N, Hauschild A.

Eur J Dermatol. 2018 Dec 1;28(6):775-783. doi: 10.1684/ejd.2018.3448.

PMID:
30698147
2.

Acne relapses: impact on quality of life and productivity.

Dreno B, Bordet C, Seite S, Taieb C; “Registre Acné” dermatologists.

J Eur Acad Dermatol Venereol. 2019 Jan 11. doi: 10.1111/jdv.15419. [Epub ahead of print]

PMID:
30633393
3.

Combination of alitretinoin and topical 5-fluorouracil in Darier disease.

Soenen A, Saint-Jean M, Daguzé J, Peuvrel L, Quéreux G, Dréno B.

JAAD Case Rep. 2018 Dec 11;5(1):75-77. doi: 10.1016/j.jdcr.2018.09.024. eCollection 2019 Jan. No abstract available.

4.

Dermatology today and tomorrow: from symptom control to targeted therapy.

Blume-Peytavi U, Bagot M, Tennstedt D, Saint Aroman M, Stockfleth E, Zlotogorski A, Mengeaud V, Schmitt AM, Paul C, Lim HW, Georgescu V, Dréno B, Nocera T.

J Eur Acad Dermatol Venereol. 2019 Jan;33 Suppl 1:3-36. doi: 10.1111/jdv.15335. Review.

PMID:
30561009
5.

Taxonomy and phylogeny of Cutibacterium (formerly Propionibacterium) acnes in inflammatory skin diseases.

Corvec S, Dagnelie MA, Khammari A, Dréno B.

Ann Dermatol Venereol. 2019 Jan;146(1):26-30. doi: 10.1016/j.annder.2018.11.002. Epub 2018 Dec 15.

PMID:
30558958
6.

Expression of Three Adipokines (Adiponectin, Leptin and Resistin) in Normal Canine Skin: a Pilot Study.

Brément T, Cossec C, Roux C, Knol AC, Dréno B, Khammari A, Bourdeau P, Bruet V.

J Comp Pathol. 2018 Nov 28. pii: S0021-9975(18)30276-7. doi: 10.1016/j.jcpa.2018.10.179. [Epub ahead of print]

PMID:
30503576
7.

Anti-PD1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature.

Sellah D, Saint-Jean M, Peuvrel L, Khammari A, Quéreux G, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Nov 19. doi: 10.1111/jdv.15352. [Epub ahead of print] No abstract available.

PMID:
30451326
8.

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.

Kandel M, Allayous C, Dalle S, Mortier L, Dalac S, Dutriaux C, Leccia MT, Guillot B, Saiag P, Lacour JP, Legoupil D, Lesimple T, Aubin F, Beylot-Barry M, Brunet-Possenti F, Arnault JP, Granel-Brocard F, Stoebner PE, Dupuy A, Maubec E, Grob JJ, Dreno B, Rotolo F, Ballon A, Michiels S, Lebbe C, Borget I.

Eur J Cancer. 2018 Dec;105:33-40. doi: 10.1016/j.ejca.2018.09.026. Epub 2018 Oct 29.

PMID:
30384014
9.

Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcome.

Bregeon B, Nguyen JM, Varey E, Quereux G, Saint-Jean M, Peuvrel L, Khammari A, Dreno B.

Eur J Dermatol. 2018 Oct 1;28(5):661-667. doi: 10.1684/ejd.2018.3402.

PMID:
30378546
10.

Akne bei erwachsenen Frauen: Physiologische und psychologische Erwägungen und Management.

Dreno B, Bagatin E, Blume-Peytavi U, Rocha M, Gollnick H.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1185-1196. doi: 10.1111/ddg.13664_g. Review. No abstract available.

PMID:
30300500
11.

First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol.

Peuvrel L, Bregeon B, Saint-Jean M, Quéreux G, Frénard C, Khammari A, Wdowik A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments.

Dermatol Ther. 2019 Jan;32(1):e12756. doi: 10.1111/dth.12756. Epub 2018 Nov 4. No abstract available.

PMID:
30285315
12.

Female type of adult acne: Physiological and psychological considerations and management.

Dreno B, Bagatin E, Blume-Peytavi U, Rocha M, Gollnick H.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1185-1194. doi: 10.1111/ddg.13664. Epub 2018 Sep 24. Review.

PMID:
30248242
13.

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features.

Simon S, Wu Z, Cruard J, Vignard V, Fortun A, Khammari A, Dreno B, Lang F, Rulli SJ, Labarriere N.

Front Immunol. 2018 Aug 30;9:1962. doi: 10.3389/fimmu.2018.01962. eCollection 2018.

14.

Decreased photosensitivity to UVA on vemurafenib combined with cobimetinib.

Frenard C, Dutartre H, Boisrobert A, Khammari A, Dreno B.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e87-e88. doi: 10.1111/jdv.15239. Epub 2018 Sep 25. No abstract available.

PMID:
30198584
15.

Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.

Hauschild A, Larkin J, Ribas A, Dréno B, Flaherty KT, Ascierto PA, Lewis KD, McKenna E, Zhu Q, Mun Y, McArthur GA.

JAMA Oncol. 2018 Oct 1;4(10):1382-1388. doi: 10.1001/jamaoncol.2018.2668.

16.

Autologous graft-versus-host disease with combined immune checkpoint blockade.

Kofler L, Dréno B, Röcken M.

Eur J Cancer. 2018 Sep;101:275-277. doi: 10.1016/j.ejca.2018.05.016. Epub 2018 Jul 13. No abstract available.

PMID:
30017386
17.

Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.

Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ.

Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4.

PMID:
29974453
18.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM.

Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13.

PMID:
29908991
19.

Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.

Dréno B, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C.

J Eur Acad Dermatol Venereol. 2018 Jun;32 Suppl 2:5-14. doi: 10.1111/jdv.15043. Review.

PMID:
29894579
20.

Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine®.

Pécastaings S, Roques C, Nocera T, Peraud C, Mengeaud V, Khammari A, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Jun;32 Suppl 2:15-23. doi: 10.1111/jdv.15042.

PMID:
29894577
21.

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy.

Herbreteau G, Vallée A, Knol AC, Théoleyre S, Quéreux G, Varey E, Khammari A, Dréno B, Denis MG.

Oncotarget. 2018 May 18;9(38):25265-25276. doi: 10.18632/oncotarget.25404. eCollection 2018 May 18.

22.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Saint-Jean M, Knol AC, Volteau C, Quéreux G, Peuvrel L, Brocard A, Pandolfino MC, Saiagh S, Nguyen JM, Bedane C, Basset-Seguin N, Khammari A, Dréno B.

J Immunol Res. 2018 Mar 19;2018:3530148. doi: 10.1155/2018/3530148. eCollection 2018.

23.

Ipilimumab more and more discussed: urgent need for predictive markers of response.

Dréno B.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):849. doi: 10.1111/jdv.15018. No abstract available.

PMID:
29706000
24.

Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.

Carlavan I, Bertino B, Rivier M, Martel P, Bourdes V, Motte M, Déret S, Reiniche P, Menigot C, Khammari A, Dreno B, Fogel P, Voegel JJ.

Br J Dermatol. 2018 Oct;179(4):906-917. doi: 10.1111/bjd.16680. Epub 2018 Aug 16.

PMID:
29663317
25.

Use of Smartphones for Early Detection of Melanoma: Systematic Review.

Rat C, Hild S, Rault Sérandour J, Gaultier A, Quereux G, Dreno B, Nguyen JM.

J Med Internet Res. 2018 Apr 13;20(4):e135. doi: 10.2196/jmir.9392. Review.

26.

Acne and nutrition: hypotheses, myths and facts.

Claudel JP, Auffret N, Leccia MT, Poli F, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1631-1637. doi: 10.1111/jdv.14998. Epub 2018 May 7. Review.

PMID:
29633388
27.
28.

Cutibacterium acnes molecular typing: time to standardize the method.

Dagnelie MA, Khammari A, Dréno B, Corvec S.

Clin Microbiol Infect. 2018 Nov;24(11):1149-1155. doi: 10.1016/j.cmi.2018.03.010. Epub 2018 Mar 12. Review.

PMID:
29544912
29.

TOXICAN: a guide for grading dermatological adverse events of cancer treatments.

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments.

Support Care Cancer. 2018 Aug;26(8):2871-2877. doi: 10.1007/s00520-018-4153-x. Epub 2018 Mar 12.

PMID:
29532244
30.

Isotretinoin treatment and peanut allergy: a new case report and review of the literature.

Paugam C, Saint-Jean M, Colas L, Bernier C, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e341-e343. doi: 10.1111/jdv.14916. Epub 2018 Mar 26. No abstract available.

PMID:
29512201
31.

Validation of 3D skin imaging for objective repeatable quantification of severity of atrophic acne scarring.

Petit L, Zugaj D, Bettoli V, Dreno B, Kang S, Tan J, Torres V, Layton AM, Martel P.

Skin Res Technol. 2018 Nov;24(4):542-550. doi: 10.1111/srt.12464. Epub 2018 Mar 6.

PMID:
29512189
32.

PD-L1 expression by tumor cell lines: A predictive marker in melanoma.

Knol AC, Nguyen JM, Pandolfino MC, Denis MG, Khammari A, Dréno B.

Exp Dermatol. 2018 Jun;27(6):647-655. doi: 10.1111/exd.13526.

33.

Why We Should Focus on Melanoma-Targeted Screening Strategies.

Rat C, Dreno B, Nguyen JM.

Dermatology. 2017;233(6):480-481. doi: 10.1159/000487080. Epub 2018 Mar 2. No abstract available.

34.

[Guide to university hospital careers in dermatology. The GRENT (Graines Engrais Tuteurs - Seed Fertilizer Plant stick) Program].

Gaudy-Marqueste C, Samimi M, Soria A, Aractingi S, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Beylot-Barry M, Dreno B.

Ann Dermatol Venereol. 2018 Mar;145(3):200-209. doi: 10.1016/j.annder.2017.11.010. Epub 2018 Feb 12. French. No abstract available.

PMID:
29449018
35.

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation-positive melanoma.

Dréno B, Ascierto PA, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Bartley K, Karagiannis T, Chang I, Rooney I, Koralek DO, Larkin J, McArthur GA, Ribas A.

Br J Cancer. 2018 Mar 20;118(6):777-784. doi: 10.1038/bjc.2017.488. Epub 2018 Feb 13.

36.

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.

Filippova A, Charles J, Epaulard O, Germi R, Persoons V, Templier I, Leccia MT, Dreno B, Malova I, Morand P, Lupo J.

Cytotherapy. 2018 Apr;20(4):521-523. doi: 10.1016/j.jcyt.2017.12.006. Epub 2018 Feb 9.

PMID:
29434005
37.

Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.

Tio D, Prinsen CAC, Dréno B, Hoekzema R, Augustin M, van Montfrans C.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1476-1484. doi: 10.1111/jdv.14850. Epub 2018 Mar 30.

PMID:
29419913
38.

Oral retinoids and depression: reply from the authors.

Le Moigne M, Fournier JP, Victorri-Vigneau C, Dréno B.

Br J Dermatol. 2018 May;178(5):1224. doi: 10.1111/bjd.16429. Epub 2018 Apr 17. No abstract available.

PMID:
29405256
39.

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Delaunay T, Violland M, Boisgerault N, Dutoit S, Vignard V, Münz C, Gannage M, Dréno B, Vaivode K, Pjanova D, Labarrière N, Wang Y, Chiocca EA, Boeuf FL, Bell JC, Erbs P, Tangy F, Grégoire M, Fonteneau JF.

Oncoimmunology. 2017 Dec 26;7(3):e1407897. doi: 10.1080/2162402X.2017.1407897. eCollection 2018.

40.

The influence of exposome on acne.

Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A.

J Eur Acad Dermatol Venereol. 2018 May;32(5):812-819. doi: 10.1111/jdv.14820. Epub 2018 Feb 15. Review.

41.

Confocal microscopy in adult women with acne.

Muguet Guenot L, Vourc'h Jourdain M, Saint-Jean M, Corvec S, Gaultier A, Khammari A, Le Moigne M, Boisrobert A, Paugam C, Dréno B.

Int J Dermatol. 2018 Mar;57(3):278-283. doi: 10.1111/ijd.13910. Epub 2018 Jan 25.

PMID:
29369333
42.

Pyoderma Gangrenosum Under Dabrafenib and Trametinib for Metastatic Melanoma.

Saint-Jean M, Le Moigne M, Daguze J, Bossard C, Peuvrel L, Quéreux G, Dréno B.

Acta Derm Venereol. 2018 Apr 27;98(5):530-531. doi: 10.2340/00015555-2890. No abstract available.

43.

Do Cutibacterium acnes and Staphylococcus aureus define two different types of folliculitis?: Bacteriological study of scalp folliculitis.

Frenard C, Dagnelie MA, Khammari A, Saint-Jean M, Boisrobert A, Corvec S, Dreno B.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e266-e268. doi: 10.1111/jdv.14793. Epub 2018 Jan 31. No abstract available.

PMID:
29341254
44.

Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.

Chasseuil E, Saint-Jean M, Chasseuil H, Peuvrel L, Quéreux G, Nguyen JM, Gaultier A, Varey E, Khammari A, Dréno B.

Acta Derm Venereol. 2018 Apr 16;98(4):406-410. doi: 10.2340/00015555-2872.

45.

5-fluorouracil chemowraps for the treatment of multiple actinic keratoses.

Peuvrel L, Saint-Jean M, Quereux G, Brocard A, Le Moigne M, Frénard C, Khammari A, Dreno B.

Eur J Dermatol. 2017 Dec 1;27(6):635-640. doi: 10.1684/ejd.2017.3128.

PMID:
29311041
46.

[On the attractiveness of a university-hospital career in medicine: Obstacles and solutions. The teachers' perspective].

Samimi M, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Soria A; le Conseil National des universitaires de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):196-199. doi: 10.1016/j.annder.2017.10.014. Epub 2017 Dec 11. French. No abstract available.

PMID:
29241631
47.

Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.

Richard MA, Amici JM, Basset-Seguin N, Claudel JP, Cribier B, Dreno B.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):339-346. doi: 10.1111/jdv.14753. Epub 2018 Jan 15.

PMID:
29235161
48.

[What future for dermatology in university hospitals?]

Dréno B, Dupin N.

Ann Dermatol Venereol. 2018 Mar;145(3):157-158. doi: 10.1016/j.annder.2017.11.012. Epub 2017 Dec 8. French. No abstract available.

PMID:
29229191
49.

[Attractiveness of a university hospital career in France: Analysis of perceptions among young dermatologists in 2016].

Soria A, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Samimi M; les membres du Collège National des universités de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):191-196. doi: 10.1016/j.annder.2017.11.003. Epub 2017 Dec 6. French. No abstract available.

PMID:
29223610
50.

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Simon S, Vignard V, Varey E, Parrot T, Knol AC, Khammari A, Gervois N, Lang F, Dreno B, Labarriere N.

Cancer Res. 2017 Dec 15;77(24):7083-7093. doi: 10.1158/0008-5472.CAN-17-1856. Epub 2017 Dec 6.

Supplemental Content

Support Center